We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > amyotrophic lateral sclerosis

News List

Amylyx Pharmaceuticals Announces New England Journal of Medicine Publication of Pivotal AMX0035 Data Demonstrating Statistically Significant Benefit in People with ALS drugs.com
September 24, 2020
Amylyx Pharmaceuticals, Inc. today announced the publication of results from the pivotal CENTAUR trial evaluating AMX0035.
Organs-on-chip technology reveals new drug candidates for Lou Gehrig's disease worldpharmanews
October 12, 2018
The investigation of amyotrophic lateral sclerosis (ALS) - also known as Lou Gehrig's disease - through muscle-on-a-chip technology has revealed a new drug combination that may serve as an effective treatment of the progressive neurodegenerative disease.
Legend Dies! Hawking’s Gone, but ALS Drug Development Should Continue Yuntian
March 27, 2018
The legendary life of Hawking ended on March 14, 2018 by when Hawking fought against the well-known amyotrophic lateral sclerosis (ALS) for 55 years.